Paper7698121
Chemotherapy of lepromatous leprosy: recent developments and prospects for the future.
Gelber RH. Eur J Clin Microbiol Infect Dis, 1994. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Chemotherapy of lepromatous leprosy: recent developments and prospects for the future. Papers, record 7698121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7698121
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leprostatic Agents | Major topic |
| Leprosy, Lepromatous | Major topic |
| Animals | |
| Drug Therapy, Combination | |
| Forecasting | |
| Humans | |
| Mice | |
| Mycobacterium leprae |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8392100 | Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice. | Int J Lepr Other Mycobact Dis | 1993 | https://conductscience.org/library/papers/8392100 | PubMed |
| 2 | 7031389 | A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation. | Lepr Rev | 1981 | https://conductscience.org/library/papers/7031389 | PubMed |
| 3 | 3549940 | Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse. | Int J Lepr Other Mycobact Dis | 1987 | https://conductscience.org/library/papers/3549940 | PubMed |
| 4 | 69411 | Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis. | Am Rev Respir Dis | 1977 | https://conductscience.org/library/papers/69411 | PubMed |
| 5 | 4562383 | Combinations of drugs against Mycobacterium leprae studied in mice. | Int J Lepr Other Mycobact Dis | 1972 | https://conductscience.org/library/papers/4562383 | PubMed |
| 6 | 661479 | Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review. | Lepr Rev | 1978 | https://conductscience.org/library/papers/661479 | PubMed |
| 7 | 6806990 | Chemotherapy of leprosy for control programmes. | World Health Organ Tech Rep Ser | 1982 | https://conductscience.org/library/papers/6806990 | PubMed |
| 8 | 1648889 | Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1648889 | PubMed |
| 9 | 3522770 | Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone. | Int J Lepr Other Mycobact Dis | 1986 | https://conductscience.org/library/papers/3522770 | PubMed |
| 10 | 8257487 | Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. | J Infect Dis | 1993 | https://conductscience.org/library/papers/8257487 | PubMed |
| 11 | 2407654 | Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae. | Infect Immun | 1990 | https://conductscience.org/library/papers/2407654 | PubMed |
| 12 | 3747702 | The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy. | Lepr Rev | 1986 | https://conductscience.org/library/papers/3747702 | PubMed |
| 13 | 795312 | Dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat. | Am J Trop Med Hyg | 1976 | https://conductscience.org/library/papers/795312 | PubMed |
| 14 | 1563772 | Vaccination of mice with a soluble protein fraction of Mycobacterium leprae provides consistent and long-term protection against M. leprae infection. | Infect Immun | 1992 | https://conductscience.org/library/papers/1563772 | PubMed |
| 15 | 7002811 | Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat. | Int J Lepr Other Mycobact Dis | 1980 | https://conductscience.org/library/papers/7002811 | PubMed |
| 16 | 49662 | Sulphone resistance in leprosy. A review of one hundred proven clinical cases. | Lancet | 1975 | https://conductscience.org/library/papers/49662 | PubMed |
| 17 | 2256685 | Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates. | Arch Dermatol | 1990 | https://conductscience.org/library/papers/2256685 | PubMed |
| 18 | 3325579 | Application of the thymectomized-irradiated mouse to the detection of persisting Mycobacterium leprae. | Int J Lepr Other Mycobact Dis | 1987 | https://conductscience.org/library/papers/3325579 | PubMed |
| 19 | 2198315 | Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. | Int J Lepr Other Mycobact Dis | 1990 | https://conductscience.org/library/papers/2198315 | PubMed |
| 20 | 4398128 | Kinetic testing of drugs against Mycobacterium leprae in mice. Activity of cephaloridine, rifampin, streptovaricin, vadrine, and viomycin. | Am J Trop Med Hyg | 1971 | https://conductscience.org/library/papers/4398128 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41699691 | Protocol of a comparative multicentric non inferiority clinical trial of WHO MBMDT with a new monthly chemotherapy regimen containing rifampicin, moxifloxacin and clarithromycin (RMC) on multibacillary patients from India. | Trials | 2026 | https://conductscience.org/library/papers/41699691 | PubMed |
| 28850614 | Nitazoxanide is active against Mycobacterium leprae. | PLoS One | 2017 | https://conductscience.org/library/papers/28850614 | PubMed |
| 27175099 | Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy. | Risk Manag Healthc Policy | 2016 | https://conductscience.org/library/papers/27175099 | PubMed |
| 22048122 | Advances and hurdles on the way toward a leprosy vaccine. | Hum Vaccin | 2011 | https://conductscience.org/library/papers/22048122 | PubMed |
| 18573938 | Powerful bactericidal activity of moxifloxacin in human leprosy. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18573938 | PubMed |
| 7698114 | Mycobacterial taxonomy. | Eur J Clin Microbiol Infect Dis | 1994 | https://conductscience.org/library/papers/7698114 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7698121
GET https://conductscience.org/api/papers/v1/7698121/references?page=2